Tmj Treatment denied due to quantity / dose limits by Cigna?

Cigna's specific coverage criteria for tmj treatment are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Applies Quantity Limits to TMJ Treatment

Quantity limits on TMJ treatment typically arise in two scenarios: a benefit-design cap on the number of covered visits, devices, or procedures per benefit period, or a medical-necessity determination that the quantity requested exceeds what Cigna considers appropriate for the diagnosis. For TMJ, this commonly affects physical therapy visit counts, the number of oral appliances, or the frequency of injections. The denial does not mean the treatment is inappropriate — it means Cigna believes the requested quantity exceeds its coverage threshold for this period.

## Why This Denial Is Appealable

Quantity-limit denials are appealable on two grounds. First, if your plan's benefit document does not explicitly impose the limit Cigna applied, the denial may contradict your plan terms — a strong appeal argument. Second, even where a plan limit exists, ACA §2719 (for ACA plans) and ERISA §503 (for employer plans) both require that clinical determinations be reviewable, and an external independent reviewer can find that your circumstances justify an exception. The external review window is generally approximately four months from the denial. Expedited review is available for urgent clinical situations.

## The Appeal Process and Timeline

1. Compare the denial to your Summary Plan Description (SPD): Confirm what the plan document actually says about visit or quantity limits for TMJ — sometimes the limit Cigna applied is stricter than what the plan document specifies. 2. File an internal appeal within the deadline on your EOB, typically 180 days. 3. Have your prescriber document why the additional quantity is medically necessary — this reframes the question from a benefit limit to a clinical necessity determination. 4. If the internal appeal fails, request external review. An independent reviewer may find that your clinical situation meets criteria for an exception.

## Documentation to Gather

• Diagnosis and severity: Current chart notes showing the TMJ diagnosis, symptom burden, and functional impact (jaw mechanics, pain, ability to eat or speak).
• Treatment response to date: Documentation of what benefit you received from the quantity already approved and why additional treatment is required for continued improvement or to prevent deterioration.
• Prescriber medical-necessity letter: A letter explicitly stating the clinical rationale for the additional quantity and referencing applicable professional society guidelines (without quoting specific numbers — the letter should cite the relevant guideline organization and direct Cigna to the full text).
• Prior authorization records: Any prior PA approvals for the same treatment that establish a documented treatment course.

## Criteria-Mapping Structure

Obtain Cigna's quantity-limit policy for the specific TMJ treatment category. For each criterion that justifies an exception (e.g., continued functional improvement, failure to plateau, risk of regression), document the chart evidence that satisfies it. If Cigna's published policy does not specify exception criteria, reference your plan's SPD language alongside the prescriber's clinical rationale.